Amanote Research

Amanote Research

    RegisterSign In

Are Improper Kinetic Models Hampering Drug Development?

doi 10.7287/peerj.preprints.521v1
Full Text
Open PDF
Abstract

Available in full text

Date

October 2, 2014

Authors
Ryan Walsh
Publisher

PeerJ


Related search

Functional GI Disorders: From Animal Models to Drug Development

Gut
Gastroenterology
2008English

A Novel ZnO Nanoparticle as Drug Nanocarrier in Therapeutic Applications: Kinetic Models and Error Analysis

Journal of the Turkish Chemical Society, Section A: Chemistry
Chemistry
2019English

Kinetic Models of Micelles Formation

Colloids and Surfaces A: Physicochemical and Engineering Aspects
SurfacesColloidInterfacesTheoretical ChemistrySurface ChemistryPhysical
2010English

Drug Development for Alzheimer's Disease: Where Are We Now and Where Are We Headed?

The American Journal of Geriatric Pharmacotherapy
2009English

Using Genetically Modified Rodent Models in Drug Development to Explore Target Physiology and Potential Drug Effects

Veterinary Pathology
Veterinary
2018English

Protein Folded States Are Kinetic Hubs

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2010English

The ERG in Drug Development: Translation From Animal Models to Human

Documenta Ophthalmologica
OphthalmologySensory SystemsPhysiology
2009English

The Gap Between Cell and Animal Models: Nanoparticle Drug-Delivery Development and Characterization Using Microtissue Models

Therapeutic Delivery
Pharmaceutical Science
2012English

Factors Hampering Innovation in Small Firms

2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy